Equity Profile

RVTY

Revvity, Inc.

Health CareLife Sciences Tools & Services$12.4B

Jul27Mon

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Revvity, Inc. is a healthcare company specializing in life sciences tools and services....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health.

Not available

Revenue Growth

Revenue growth is essential to assess how well Revvity is expanding its business and capturing market share.

Not available

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

RVTY Q2-2026 Earnings Preview

Context

Company Snapshot

Revvity, Inc. is a healthcare company specializing in life sciences tools and services. With a market cap of $12 billion, it plays a crucial role in advancing medical research and diagnostics, which are increasingly important in today's health-focused environment.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+6.07%

Avg Stock Reaction

+0.94%

Last Quarter Recap

In Q1 2026, Revvity reported an EPS of $1.04, slightly beating expectations of $1.02. The stock reacted positively, gaining 6.69% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of the earnings report, given Revvity's strong track record of beating EPS estimates.

Bull Case

If Revvity continues its trend of beating EPS estimates, it could signal robust demand for its products and services, leading to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could raise concerns about future growth, potentially leading to a decline in the stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

Given Revvity's history of beating EPS estimates, this figure will be crucial in determining market sentiment.

How is Revvity addressing competitive pressures in the life sciences sector?

Understanding the company's strategy in a competitive landscape will be vital for assessing future growth potential.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Revvity's ability to outperform due to its strong product pipeline and market demand.

Supporting Evidence

Revvity has consistently beaten EPS estimates, indicating strong operational execution.

The options market is pricing a larger move than historical averages, suggesting heightened expectations.

Recent trends in the healthcare sector show increasing investment in life sciences tools, which could benefit Revvity.

Key Risk

If Revvity's EPS comes in below $1.00, it could invalidate the current bullish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be closely scrutinized to gauge the company's ability to sustain its growth amidst market challenges.

Bull Confirmed If

An EPS of $1.10 or higher would confirm strong operational performance and growth.

Bear Confirmed If

An EPS below $1.00 would raise concerns about Revvity's growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±5.73%

Historical Avg

±4.0%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±5.7% while RVTY has averaged ±4.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

50.1%

Calls (5K)P/C Ratio: 1.43Puts (800)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Revvity beats expectations, history suggests the stock could rise by around 0.94%, confirming the bullish sentiment.

In-Line / Cautious

If results are in line but cautious commentary is provided, the stock may experience muted movement as investors reassess their outlook.

Miss

A miss on EPS could lead to a decline, potentially around 0.94%, as it would raise doubts about the company's growth prospects.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in the pipeline.
2Management's outlook on market trends and competitive landscape.
3Details on revenue growth in key segments.
4Insights into operational efficiencies and cost management.
5Any changes in guidance or expectations for the upcoming quarters.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aon plc

Company Snapshot

Revvity, Inc. is a healthcare company specializing in life sciences tools and services....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health.

Not available

Revenue Growth

Revenue growth is essential to assess how well Revvity is expanding its business and capturing market share.

Not available

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

RVTY Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+6.07%

Avg Stock Reaction

+0.94%

Last Quarter Recap

In Q1 2026, Revvity reported an EPS of $1.04, slightly beating expectations of $1.02. The stock reacted positively, gaining 6.69% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of the earnings report, given Revvity's strong track record of beating EPS estimates.

Bull Case

If Revvity continues its trend of beating EPS estimates, it could signal robust demand for its products and services, leading to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could raise concerns about future growth, potentially leading to a decline in the stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

Given Revvity's history of beating EPS estimates, this figure will be crucial in determining market sentiment.

How is Revvity addressing competitive pressures in the life sciences sector?

Understanding the company's strategy in a competitive landscape will be vital for assessing future growth potential.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Revvity's ability to outperform due to its strong product pipeline and market demand.

Supporting Evidence

Revvity has consistently beaten EPS estimates, indicating strong operational execution.

The options market is pricing a larger move than historical averages, suggesting heightened expectations.

Recent trends in the healthcare sector show increasing investment in life sciences tools, which could benefit Revvity.

Key Risk

If Revvity's EPS comes in below $1.00, it could invalidate the current bullish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be closely scrutinized to gauge the company's ability to sustain its growth amidst market challenges.

Bull Confirmed If

An EPS of $1.10 or higher would confirm strong operational performance and growth.

Bear Confirmed If

An EPS below $1.00 would raise concerns about Revvity's growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±5.73%

Historical Avg

±4.0%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±5.7% while RVTY has averaged ±4.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

50.1%

Calls (5K)P/C Ratio: 1.43Puts (800)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Revvity beats expectations, history suggests the stock could rise by around 0.94%, confirming the bullish sentiment.

In-Line / Cautious

If results are in line but cautious commentary is provided, the stock may experience muted movement as investors reassess their outlook.

Miss

A miss on EPS could lead to a decline, potentially around 0.94%, as it would raise doubts about the company's growth prospects.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in the pipeline.
2Management's outlook on market trends and competitive landscape.
3Details on revenue growth in key segments.
4Insights into operational efficiencies and cost management.
5Any changes in guidance or expectations for the upcoming quarters.